1 |
Kahn C, Line S. 2005. The Merk Veterinary Manual. (9th ed.). New jersey: Merck Sharp & Dohme Corp. pp. 935-953.
|
2 |
Lefebre H, Laroute V, et al. 1996. Non-invasive and quantitative evaluation of post-injection muscle damage by pharmacokinetic analysis of creatine kinase release. Vet Res 27: 343-361.
|
3 |
Nouws JFM. 1984. Irritation, bioavailability, and residue aspects of ten oxytetracycline formulations adiministered intramuscularly to pigs. Vet Quart 6: 80-84.
DOI
|
4 |
Nouws, Smulders, Rappalini. 1990. A comparative study on irritation and residue aspects of five oxytetracycline formulations administered intramuscularly to calves, pigs and sheep. Vet Quart 12: 129-138.
DOI
|
5 |
Otake S, Dee SA, Rossow KD, Joo HS, Deen J, Molitor TW, Pijoan C. 2002. Transmission of porcine reproductive and respiratory syndrome virus by needles. Vet Rec 150: 114-115.
DOI
|
6 |
Thomas E, Caldow GL, Borrell D, Davot JL. 2001. A field comparison of the efficacy and tolerance of marbofloxacin in the treatment of bovine respiratory disease. J Vet Pharmacol 24: 353-358.
DOI
|
7 |
Trinh H, Billington S, Field A, Songer J, Jost B. 2002. Susceptibility of Arcanobacterium pyogenes from different sources to tetracycline, macrolide and lincosamide antimicrobial agent. Vet Microbiol 85: 353-359.
DOI
|
8 |
Valtulini S, Macchi C, Ballanti P, Cherel Y, Laval A, Theaker JM, Bak M, Ferretti E, Morvan H. 2005. Aluminium hydroxide-induced granulomas in pigs. Vaccine 23: 3999-4004.
DOI
|
9 |
Yu-Ri Park, Da-Rae Lim, Hye-Ryung Kim, Min-Ji Park, Bumseok Kim, Won-Il Kim, Chang-Ho Hong, Sung-Nyon Kim, Choi-Kyu Park. 2017. Evaluation of efficacy of a commercial vaccine stress-relieving agent to reduce the adverse effects of foot-andmouth disease vaccination site in pig. Kor J Vet Serv 40(3): 177-185.
DOI
|
10 |
Anna R, James A. 2003. Adjuvants in veterinary vaccines: Modes of action and adverse effects. J Vet Intern Med 17: 273-281.
DOI
|
11 |
Applbaum PC, Hunter PA. 2000. The fluoroquinolone antibacterials: past, present and future perspective. Int J Antimicrob Agents 16: 5-15
DOI
|
12 |
Bryce M, Terry A, Larry C, Michael D, Jerome C, James J, Gary A, Brandon L. 2012. Incidence and severity of Arcanobacterium pyogenes injection site abscesses with needle or needle-free injection. Meat Science 92: 805-807.
DOI
|
13 |
Dubeski P, Aalhus J, Donkersgoed J, Vanderkop M. 2001. Tenderness of beef round muscles containing injection site lesions or bruises. Can J Anim Sci. 81: 441-449.
DOI
|
14 |
George M, Heinrich P, Dexter D, Morgan J, Odde K, Glock R. 1995. Injection-site lesions in carcasses of cattle receiving injections at branding and at weaning. J Anim Sci 73: 3235-3240.
DOI
|
15 |
Choi SH, Pak SI. 2015. Economic burden of foot-and-mouth disease vaccination induced injection site lesions in slaughtered pigs and its causal relationship. J Prev Med Public Heath 39:153-156.
|
16 |
Christensen G, Sorensen V, Mousing J. 1999. Disease of the respiratory system. Disease of Swine. pp. 913-940.
|
17 |
Dudley MN. 1991. Pharmacodynamics and pharmacokinetics of antibiotics with special references to the fluoroquinolones. Am J Med 30: 45-50.
|
18 |
Eun Young Ko, Samooel Jung, Hyun Kyu Jeong. 2018. Effects of Foot-and-mouth Disease Vaccination location and injection device on the incidence of site lesion in pork. Korean J Food Sci Anim Resour 38(3): 498-505.
DOI
|
19 |
Harper A. 2008. Injection use and quality assured pork. Livestock update. Virginia Cooperative Extension.
|